Vagus nerve stimulation: how to reset your vagus nerve, and what the evidence shows
You can't reset your vagus nerve, but you can shift vagal tone. Here's what implants, ear devices, breathing, humming and cold water actually do.

Short answer
Vagus nerve stimulation (VNS) means activating the vagus nerve on purpose — with an FDA-approved implant (used since 1997 for epilepsy and since 2005 for hard-to-treat depression), a prescription neck device for headaches, or free habits like breathing at about six breaths per minute. You can't "reset" the nerve, but you can shift vagal tone.
If your body feels stuck in overdrive, you're not broken, and it's not a character flaw. Your vagus nerve hasn't snapped or switched off. A racing heart, a tight chest, and a mind that won't settle are signs of a nervous system that has spent a long time on high alert. That state can shift, and some of the tools that shift it are free and measurable.
This article separates the three things people mean by vagus nerve stimulation: medical implants, non-invasive neck and ear devices, and everyday methods like slow breathing, humming, and cold water on the face. For each, we cover what the research actually shows, where it is strong, where it is thin, and how to use it safely — including for anxiety.
What is vagus nerve stimulation?
The vagus nerve is the longest cranial nerve. It runs from the brainstem through the neck and chest into the abdomen, and it connects the brain with the heart, lungs, and gut. It is the main nerve of the parasympathetic, or "rest-and-digest," branch of the nervous system. Most of its traffic actually flows upward: it carries information about the state of your organs back to the brain, which is one reason it matters for mood and stress as well as digestion and heart rate. (doi.org) For a full tour of the nerve itself, see what the vagus nerve is and what it does.
"Vagus nerve stimulation" gets used for three quite different things:
Implanted VNS. A surgeon places a small pulse generator under the skin of the chest and connects a wire to the vagus nerve in the neck. The device sends programmed electrical pulses on a schedule. This is a regulated medical therapy.
Non-invasive VNS. A handheld or wearable device stimulates the nerve through the skin, either on the side of the neck or on the outer ear. One neck device is FDA-cleared for headache; most ear devices are still being studied.
Natural vagus nerve stimulation. Slow breathing, humming, cold water on the face, and exercise. These don't send electricity into the nerve. They change body signals — breathing rhythm, blood pressure, face temperature — that the brain answers partly through the vagus nerve.
These are not interchangeable. An implant for drug-resistant epilepsy and a five-minute breathing exercise share a nerve, not a level of evidence or a level of risk.
How do you reset your vagus nerve?
Here is the honest answer to "how to reset vagus nerve": there is nothing to reset. The vagus nerve isn't a circuit breaker that trips and needs flipping back. What changes from day to day, and from person to person, is vagal tone — how strongly the vagus nerve is slowing and steadying the heart at a given moment, and how quickly it brings you back down after stress.
Researchers can't measure vagal tone directly in everyday life, so they estimate it from heart rate variability (HRV), the tiny changes in time between one heartbeat and the next. When the vagus nerve is more active, the heart speeds up slightly as you breathe in and slows as you breathe out, and beat-to-beat variation grows. Measures such as RMSSD (a time-based HRV score) and high-frequency HRV are the most closely tied to this vagal influence on the heart. (doi.org) We explain the measure in more depth in what HRV measures.
So when people say they want to "reset" their vagus nerve, what they usually want is one of two things:
A fast downshift in the moment — to stop a stress spiral, calm a racing heart, or fall asleep. Slow breathing and cold water on the face can do this within minutes.
A higher baseline over weeks — a body that recovers faster and doesn't stay on alert. That comes from repeated practice, regular exercise, and enough sleep, not from one trick.
Long stretches of stress, poor sleep, illness, alcohol, and pain all tend to push HRV down. That doesn't mean the nerve is damaged. It means the system is carrying a load. If you recognize the feeling of being "wired but tired" and unable to switch off, why your body stays in stress mode and can't relax and what nervous system dysregulation really means go deeper.
Which vagus nerve stimulation devices are FDA-approved?
A vagus nerve stimulation device can mean anything from a surgically implanted system to a $300 ear clip sold online. Only a few devices have been reviewed by the US Food and Drug Administration (FDA) for specific medical uses:
| Device type | How it works | FDA status (checked September 2026) |
|---|---|---|
| VNS Therapy System (implanted) | Pulse generator in the chest, wire on the left vagus nerve in the neck | Approved 1997 for drug-resistant partial-onset seizures, extended in 2017 to age 4 and older; approved 2005 as add-on long-term treatment for adults with chronic or recurrent depression that hasn't responded to four or more treatments |
| Vivistim Paired VNS System (implanted) | Short bursts of stimulation paired with arm rehabilitation exercises | Approved 2021 to improve arm movement in chronic ischemic stroke with moderate to severe arm weakness |
| SetPoint System (implanted) | Small stimulator on the vagus nerve in the neck, aimed at the nerve's anti-inflammatory reflex | Approved 2025 for adults with moderate to severe rheumatoid arthritis who haven't done well on advanced drug therapy |
| gammaCore (handheld, neck) | Stimulates through the skin on the side of the neck | First authorized 2017 for cluster headache; now cleared for migraine (from age 12) and several other headache disorders |
| Ear-based percutaneous stimulators | Tiny needles or electrodes in and around the ear | A few cleared for narrow uses, such as easing opioid withdrawal symptoms |
What about the consumer ear devices you see advertised, such as Parasym's Nurosym? Parasym markets Nurosym in Europe as a CE-marked medical device. When we searched FDA's public device databases in September 2026, we found no FDA clearance or approval for it, and it is not an FDA-authorized treatment for anxiety, stress, sleep, or any other condition. The same applies to most "vagus nerve stimulator" gadgets sold for calm or recovery.
A simple test before buying: Is this device authorized for a specific diagnosis, or is it a wellness product borrowing medical language? If it claims to treat anxiety, trauma, POTS, IBS, inflammation, or "vagal shutdown" without a specific clearance, treat the claim as marketing until proven otherwise.
Does implanted vagus nerve stimulation work?
For the conditions it's approved for, yes — but more modestly and more slowly than the phrase "nerve stimulation" might suggest.
Epilepsy. A meta-analysis of 74 studies with 3,321 people with drug-resistant epilepsy found that seizures fell by an average of 45% after VNS, and about half of patients had their seizures cut by at least half. Complete seizure freedom was rare, and about a quarter of patients got no benefit. (doi.org) A Cochrane review of five randomized trials concluded that VNS for focal seizures appears effective and well tolerated as an add-on to medication. (doi.org)
Depression. The evidence is real but mixed. In the original 10-week sham-controlled trial of 235 people with treatment-resistant depression, response rates were 15.2% with active VNS and 10.0% with sham — not a significant difference. (doi.org) Benefit, when it comes, tends to build over many months. In the RECOVER study, 214 adults with markedly treatment-resistant depression continued VNS for a second year: among those who had benefited by 12 months, about 80% still had that benefit at 24 months, and roughly 30% of those with no meaningful benefit at 12 months improved during the second year. The study was open-label in its second year and was sponsored by the device maker (LivaNova). (doi.org)
Stroke recovery. In the VNS-REHAB trial, 108 people with long-standing arm weakness after stroke all received an implant and six weeks of rehabilitation; only half had the stimulator switched on. Ninety days after therapy, 47% of the active group had a clinically meaningful improvement in arm function, compared with 24% of the sham group. (doi.org)
Rheumatoid arthritis. The vagus nerve also dampens inflammation. In the RESET-RA trial of 242 people whose rheumatoid arthritis hadn't responded to advanced drugs, 35.2% had at least a 20% improvement after three months of active stimulation, compared with 24.2% on sham. Serious device-related problems (1.6%) were all linked to surgery and resolved. (doi.org)
The pattern across all four: implanted VNS helps a meaningful share of people with serious conditions that other treatments haven't controlled. It is not a cure-all, and it is not a wellness tool.
What is non-invasive vagus nerve stimulation?
Non-invasive vagus nerve stimulation reaches the nerve through the skin, without surgery. There are two main sites: the side of the neck, where the main trunk of the vagus nerve runs close to the surface, and the outer ear, where a small sensory branch reaches the skin.
The two sites are not equivalent. The main nerve in the neck carries signals in both directions and contains five to six times more large sensory fibers than the ear branch, which only carries signals toward the brain. In a small randomized lab study, stimulating both sides of the neck lowered systolic blood pressure in 9 young adults (from 134 to 120 mmHg on average) and increased relaxed alpha brain waves, while stimulating the ear at the cymba conchae (the hollow above the ear canal) or the tragus (the small flap in front of it) did neither. (doi.org) That's one small study in healthy people, but it fits a broader picture: where you stimulate matters.
Neck devices for headache. The best-tested non-invasive device is gammaCore. In the PRESTO trial of 243 people with migraine, more people were pain-free 30 minutes after an attack with the real device than with sham (12.7% vs 4.2%) and at 60 minutes (21.0% vs 10.0%). But the trial's main goal, pain freedom at two hours, was not met (30.4% vs 19.7%). (doi.org) In the PREMIUM trial of daily use to prevent migraine, the device didn't beat sham overall: migraine days fell by 2.26 a month with gammaCore and 1.80 with sham. The researchers later found the sham device gave some real stimulation, which complicates the comparison. (doi.org)
That is what honest evidence for non-invasive VNS looks like: some real effects, some missed targets, and a field still working out the right settings.
Does ear vagus nerve stimulation work?
Ear vagus nerve stimulation, or transcutaneous auricular VNS (taVNS), is the form behind most consumer gadgets: a clip or earbud electrode delivers a mild current to the outer ear. It's safe for most people, but its benefits are much less certain than the marketing suggests.
On HRV, the answer so far is no. A living Bayesian meta-analysis pooled 16 sham-controlled studies in healthy people and found strong evidence that a session of taVNS does not change vagally mediated HRV compared with sham. (doi.org) That matters, because many devices promise to "boost vagal tone," and HRV is the main way to measure it.
On symptoms, the evidence is early and low quality. A meta-analysis of 12 randomized trials with 838 people with depression found that taVNS lowered depression scores, but rated the certainty of the evidence as low to very low. (doi.org) Trials in insomnia, digestive complaints, and pain show similar patterns: promising average effects from small studies, many from single centers, with varied stimulation settings and sham conditions that don't always keep participants blind.
On safety, the picture is reassuring. A systematic review of 177 studies covering 6,322 participants found no difference in the risk of side effects between active taVNS and control conditions. The most common complaints were ear pain, headache, and tingling. More than half the studies didn't report side effects at all, so rare problems could be missed. (doi.org)
If you want to try an ear device, think of it as an experiment with a modest expected effect, not a treatment. And if the thing you want is a measurable shift in vagal tone, slow breathing has much stronger evidence behind it.
Does vagus nerve stimulation help anxiety?
Vagus nerve stimulation for anxiety is one of the most searched uses and one of the least proven.
The link between anxiety and vagal activity is real. A meta-analysis of 36 studies comparing 2,086 people with anxiety disorders to 2,294 controls found lower resting HRV in panic disorder, PTSD, generalized anxiety disorder, and social anxiety disorder, with a small-to-moderate effect size. (doi.org) That's an association, not proof that low vagal tone causes anxiety — but it's why the idea of stimulating the nerve makes sense. We look at what this looks like in everyday life in high-functioning anxiety and what your body shows.
What the device research shows:
Implanted VNS: only an open-label pilot. Of 11 people with treatment-resistant OCD, panic disorder, or PTSD, three responded in the first 12 weeks, and four were still using VNS with sustained improvement four years later. (doi.org) With no control group, this can't separate the device from time, expectation, and other care.
Ear stimulation: in a trial of 97 chronic worriers, those who received taVNS reported fewer intrusive negative thoughts before a worry task than those given sham stimulation to the earlobe, but results after the worry task were mixed and HRV didn't change. (doi.org) In a 2026 review of 14 randomized trials in people with sleep disorders, taVNS lowered anxiety scale scores (standardized mean difference −0.53), but the authors called the results preliminary. (doi.org)
What has stronger backing is the "natural" route. A meta-analysis of 24 studies with 484 participants found that HRV biofeedback — slow breathing guided by real-time heart rhythm feedback — was linked to a large reduction in self-reported stress and anxiety compared with control conditions (Hedges' g = 0.83), though the authors called for more well-controlled trials. (doi.org) A separate meta-analysis of randomized trials found breathwork in general produced smaller but consistent reductions in stress and anxiety. (doi.org)
None of these replace proven anxiety treatments like cognitive behavioral therapy or medication. They work best alongside them. For the options that have the most evidence, see our guide to anxiety treatment.
How to stimulate your vagus nerve naturally
If you're wondering how to stimulate the vagus nerve at home, start with the method that has the most evidence and costs nothing: slow breathing. Keep the rest as extras. For a longer list of practices and what each one shifts, see vagus nerve exercises and what actually shifts vagal tone.
Slow breathing at about six breaths per minute
A systematic review and meta-analysis of 223 studies found that voluntary slow breathing raises vagally mediated HRV during the practice, right after a single session, and after multi-session programs. (doi.org)
Why it works: when you breathe in, heart rate rises a little; when you breathe out, it falls. At around six breaths per minute, that heart-rate wave lines up with the body's blood-pressure reflexes and becomes much larger. Each adult has a personal "resonance frequency," usually somewhere between 4.5 and 6.5 breaths per minute, which HRV biofeedback practitioners find by testing several rates. (doi.org)
How to try it:
Sit or lie comfortably. Breathe in through your nose for about 4 seconds.
Breathe out slowly for about 6 seconds, without forcing the air out.
Keep going for 5 to 10 minutes. That's about six breaths a minute.
If you feel light-headed, breathe more gently rather than more deeply. The aim is slow, not big.
A longer out-breath than in-breath is a common and comfortable variation. For more ways to raise your baseline over time, see how to improve HRV.
Exercise and sleep
Regular aerobic training is the slow, reliable way to lift vagal tone. In a meta-analysis of 13 studies with 322 participants, exercise training increased high-frequency HRV with a moderate effect size (d = 0.48); the effect was smaller in older people. (doi.org) Sleep matters too: short or broken nights are one of the most common reasons HRV dips. Our article on HRV during sleep explains what changes overnight and how to read it.
Does humming stimulate the vagus nerve?
Possibly a little — but mostly because humming slows your breathing. Does humming stimulate the vagus nerve is a common question, and the idea is plausible: branches of the vagus nerve supply the throat and voice box. But the direct evidence is thin.
The clearest study is a small pilot of 16 healthy adults. Five minutes of humming breathing (Bhramari, a yoga practice in which you hum on a long exhale) raised broad HRV measures compared with sitting quietly. Relaxation scores rose in all three conditions, including quiet rest, and humming did no better than slow breathing on either HRV or mood. But humming worked no better than plain slow breathing at 5 seconds in, 5 seconds out, and the HRV scores that rose were broad ones rather than the measures most specific to the vagus nerve. (doi.org)
In practice, humming is a long, slow exhale with sound. If you find it easier or more pleasant than counting breaths, it's a perfectly good way to slow down. There's no good evidence that the vibration itself does anything special, and no study has shown that humming changes anxiety or HRV over weeks.
Does cold water on your face stimulate the vagus nerve?
Yes — this one has a clear, well-understood mechanism. Cold water on the face triggers part of the diving reflex: nerves in the face sense the cold and signal the brainstem, which slows the heart through the vagus nerve.
In a lab study of 8 healthy volunteers, putting the face into cold water raised high-frequency HRV, a marker of vagal activity, whether people held their breath or kept breathing. The researchers concluded that the slowing of the heart came mainly from the vagus nerve, not from bending over a basin or from holding the breath. (doi.org) The response is strong but varies a lot between people.
What we don't have is good evidence that cold water vagus nerve tricks help anxiety or raise HRV over time. They are a quick way to interrupt a surge of stress, not a long-term treatment.
To try it: fill a bowl with cool (not icy) water, or use a cold, wet cloth, and hold it to your forehead, eyes, and cheeks for 15 to 30 seconds while breathing normally.
Be careful if you:
have fainted before, or have vasovagal syncope — a strong vagal response can trigger a faint; see POTS, dysautonomia, and vasovagal syncope;
have a slow heart rate, heart block, or another rhythm problem;
have heart disease, or are pregnant.
In those cases, ask your doctor first. And don't confuse a cool face splash with ice baths or cold plunges, which put a much bigger load on the heart.
Comparing the options
| Method | Evidence for shifting vagal activity | Evidence for symptoms | Main caution |
|---|---|---|---|
| Slow breathing (~6/min) | Strong: meta-analysis of 223 studies | Moderate for stress and anxiety (biofeedback) | Light-headedness if you over-breathe |
| Cold water on the face | Clear reflex, short-lived | Not studied well | Fainting or rhythm problems |
| Humming | Weak: one pilot of 16 people | Not studied | None known |
| Regular exercise | Moderate: meta-analysis of 13 studies | Broad health benefits | Build up gradually |
| Ear devices (taVNS) | No effect on HRV in pooled trials | Early, low-quality | Mild ear pain, headache |
| Neck device (gammaCore) | Some effects in trials | FDA-cleared for headache only | Prescription device |
| Implanted VNS | Direct nerve stimulation | Proven for epilepsy; approved for depression, stroke rehab, RA | Surgery and side effects |
Is vagus nerve stimulation safe?
It depends on the type. Is vagus nerve stimulation safe has a different answer for a breathing exercise than for an implant.
Implanted VNS means surgery, with its usual risks such as infection, and a small risk of injury to the nerve that controls the vocal cords — the one serious surgery-related problem in the VNS-REHAB stroke trial was a partial vocal cord paralysis. (doi.org) The most common ongoing side effect is voice change or hoarseness while the device is firing. In a Cochrane review, hoarseness was about twice as common with high-level stimulation as with low-level stimulation (risk ratio 2.17), and shortness of breath was also more frequent (risk ratio 2.45). (doi.org) Settings are adjusted by the treating team, and people with implants need to follow specific rules for MRI scans. (fda.gov)
Neck devices are prescription products for a reason. In authorizing gammaCore, the FDA noted that safety and effectiveness had not been established in children (it was later cleared for adolescents 12 and older with migraine), pregnant women, or people with pacemakers or other active implants, narrowed neck arteries, a past cut to the vagus nerve, uncontrolled high blood pressure, heart disease, a prolonged QT interval or arrhythmia, an abnormal ECG, or a history of seizures. (fda.gov)
Ear devices mostly cause mild, short-lived effects such as ear pain, tingling, skin redness, or headache. (doi.org) Because they're not tested in people with heart rhythm problems, implanted devices, or pregnancy, talk to a doctor first if any of those apply to you.
Natural methods are low-risk for most people. Stop if slow breathing makes you dizzy or panicky, and take care with cold water if you faint easily.
When to see a doctor
A vagus nerve "hack" shouldn't be the first response to new or worrying symptoms. See a doctor if you have:
fainting or near-fainting, especially during exercise or with no clear trigger;
a heartbeat that is very fast, very slow, or irregular, or palpitations that keep coming back;
dizziness every time you stand up;
anxiety or panic attacks that are frequent, getting worse, or stopping you from working, sleeping, or going out;
low mood that lasts more than two weeks;
digestive symptoms that don't settle, such as ongoing nausea, bloating, or bowel changes, or any bleeding, black stools, or unexplained weight loss;
any new symptom after starting a vagus nerve device.
Get emergency help right away for chest pain, fainting with injury, sudden severe shortness of breath, or thoughts of harming yourself.
How to bring this up with your doctor — and what to ask for
Say it plainly. "I've been feeling constantly on edge, my heart races, and I've read about vagus nerve stimulation. I want to understand what's going on and what might help." That gives your doctor both the symptoms and the question.
Bring context. When it started, what makes it better or worse, how you're sleeping, and any medications or supplements. If you track HRV, resting heart rate, or sleep, a few weeks of trends — plus notes on what was happening on bad days — is more useful than a single reading.
Ask these specifically. Could a heart rhythm problem, thyroid issue, blood pressure change, or medication be contributing? Would it help to check for orthostatic intolerance, such as a standing test? Would HRV biofeedback or a structured breathing program be a reasonable add-on for me? Is there any device approved for my specific condition, and am I a candidate? Is it safe for me to use cold water or an ear stimulator, given my heart history?
If you are dismissed. "I understand these symptoms can be stress-related, but they're affecting my daily life. Can we rule out physical causes and note this in my record, or can you refer me to someone who can help?" If anxiety is the main issue, ask for a referral to a therapist trained in cognitive behavioral therapy.
How Welltory helps
Welltory can't see your vagus nerve, and no wearable can. What it can do is show one of the nerve's clearest footprints — your heart rate variability — alongside the things that move it.
Every day, Welltory tracks your HRV, resting heart rate, sleep, activity, and stress load, and compares them with your own baseline rather than a population average. Morning measurements show how recovered you are before the day starts. Over a few weeks, you can see whether short nights, late alcohol, a hard training block, or a tense stretch at work pull your HRV down — and how many days it takes to come back.
You can also test the methods in this article on yourself. Take a measurement, do five minutes of slow breathing or a cold-water face splash, and measure again. One session won't change your baseline, and single readings are noisy, but repeated over a couple of weeks, the pattern tells you what your body responds to. With My Patterns, you can tag entries like "breathing practice," "cold water," "ear device," or "anxious day," and see what tends to come before your better and worse days.
Welltory won't diagnose anxiety or a heart problem, and it won't tell you whether a device is working as a treatment. What it gives you is a timeline — something concrete to show your doctor instead of "I just feel off."
How we made it
This article is based on published research, systematic reviews, and FDA device records: the anatomy and function of the vagus nerve (Breit et al. 2018), HRV as a marker of cardiac vagal tone (Laborde, Mosley & Thayer 2017), FDA premarket approval and clearance records for VNS Therapy, Vivistim, the SetPoint System, gammaCore and the Sparrow ear stimulator, implanted VNS for epilepsy (Englot et al. 2011; Panebianco et al. 2022), depression (Rush et al. 2005; Conway et al. 2026), stroke rehabilitation (Dawson et al. 2021) and rheumatoid arthritis (Tesser et al. 2025), non-invasive neck stimulation for migraine (Tassorelli et al. 2018; Diener et al. 2019), cervical versus auricular stimulation (Ahmed et al. 2026), ear stimulation and HRV (Wolf et al. 2021), depression (Tan et al. 2023), anxiety and worry (Burger et al. 2019; Lin et al. 2026) and safety (Kim et al. 2022), VNS for anxiety disorders (George et al. 2008), HRV in anxiety disorders (Chalmers et al. 2014), slow breathing and resonance frequency (Laborde et al. 2022; Shaffer & Meehan 2020), HRV biofeedback and breathwork (Goessl et al. 2017; Fincham et al. 2023), humming (Woo & Kim 2025), cold-water face immersion (Kinoshita et al. 2006), and exercise (Sandercock et al. 2005). We checked the FDA status of consumer devices in FDA's public databases in September 2026. No Welltory user data is used in this article.


Discounts for blog readers: up to 36% off
See what affects your energy, stress, sleep, and daily state with Welltory
This article is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment from a qualified clinician.
Was this helpful?
Ask AI for a summary of page
Written by Jane Smorodnikova
The founder and CEO of Welltory. A recognized tech leader with two Master's degrees and experience at MIT, she has scaled Welltory to over 17 million users.
Written by Kseniia Iaroslavtseva
Reviewed by Anna Elitzur
With her medical degree, Anna reviews Welltory's health content for medical accuracy and alignment with current clinical guidelines and research.
References
- Breit S, Kupferberg A, Rogler G, Hasler G. Vagus nerve as modulator of the brain–gut axis in psychiatric and inflammatory disorders. Frontiers in Psychiatry 2018;9:44. https://doi.org/10.3389/fpsyt.2018.00044
- Laborde S, Mosley E, Thayer JF. Heart rate variability and cardiac vagal tone in psychophysiological research – recommendations for experiment planning, data analysis, and data reporting. Frontiers in Psychology 2017;8:213. https://doi.org/10.3389/fpsyg.2017.00213
- U.S. Food and Drug Administration. Premarket approval P970003: VNS Therapy System (original approval 1997; depression indication S050, 2005; epilepsy age 4 and older S207, 2017). https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P970003
- U.S. Food and Drug Administration. Premarket approval P210007: Vivistim Paired VNS System. 2021. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P210007
- U.S. Food and Drug Administration. Premarket approval P240039: SetPoint System. 2025. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P240039
- U.S. Food and Drug Administration. De Novo classification DEN150048: gammaCore Non-invasive Vagus Nerve Stimulator. 2017. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?id=DEN150048
- U.S. Food and Drug Administration. 510(k) K211856: gammaCore Sapphire, indications for use. 2021. https://www.accessdata.fda.gov/cdrh_docs/pdf21/K211856.pdf
- U.S. Food and Drug Administration. 510(k) K201873: Sparrow Therapy System. 2021. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K201873
- Englot DJ, Chang EF, Auguste KI. Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response. Journal of Neurosurgery 2011;115(6):1248-1255. https://doi.org/10.3171/2011.7.JNS11977
- Panebianco M, Rigby A, Marson AG. Vagus nerve stimulation for focal seizures. Cochrane Database of Systematic Reviews 2022;7:CD002896. https://doi.org/10.1002/14651858.CD002896.pub3
- Rush AJ, Marangell LB, Sackeim HA, et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biological Psychiatry 2005;58(5):347-354. https://doi.org/10.1016/j.biopsych.2005.05.025
- Conway CR, Rush AJ, Aaronson ST, et al. Durability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial report. International Journal of Neuropsychopharmacology 2026;29(1):pyaf080. https://doi.org/10.1093/ijnp/pyaf080
- Dawson J, Liu CY, Francisco GE, et al. Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial. The Lancet 2021;397(10284):1545-1553. https://doi.org/10.1016/S0140-6736%2821%2900475-X
- Tesser JRP, Crowley AR, Box EJ, et al. Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial. Nature Medicine 2026;32(1):369-378. https://doi.org/10.1038/s41591-025-04114-7
- Tassorelli C, Grazzi L, de Tommaso M, et al. Noninvasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study. Neurology 2018;91(4):e364-e373. https://doi.org/10.1212/WNL.0000000000005857
- Diener HC, Goadsby PJ, Ashina M, et al. Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: the multicentre, double-blind, randomised, sham-controlled PREMIUM trial. Cephalalgia 2019;39(12):1475-1487. https://doi.org/10.1177/0333102419876920
- Ahmed R, Coello A, Pillutla AS, Telwar G, Stauss HM. Acute transcutaneous cervical but not auricular vagus nerve stimulation increases alpha wave brain activity and lowers arterial blood pressure. American Journal of Physiology – Regulatory, Integrative and Comparative Physiology 2026;330(1):R49-R59. https://doi.org/10.1152/ajpregu.00219.2025
- Wolf V, Kühnel A, Teckentrup V, Koenig J, Kroemer NB. Does transcutaneous auricular vagus nerve stimulation affect vagally mediated heart rate variability? A living and interactive Bayesian meta-analysis. Psychophysiology 2021;58(11):e13933. https://doi.org/10.1111/psyp.13933
- Tan C, Qiao M, Ma Y, Luo Y, Fang J, Yang Y. The efficacy and safety of transcutaneous auricular vagus nerve stimulation in the treatment of depressive disorder: a systematic review and meta-analysis of randomized controlled trials. Journal of Affective Disorders 2023;337:37-49. https://doi.org/10.1016/j.jad.2023.05.048
- Kim AY, Marduy A, de Melo PS, et al. Safety of transcutaneous auricular vagus nerve stimulation (taVNS): a systematic review and meta-analysis. Scientific Reports 2022;12:22055. https://doi.org/10.1038/s41598-022-25864-1
- Chalmers JA, Quintana DS, Abbott MJ, Kemp AH. Anxiety disorders are associated with reduced heart rate variability: a meta-analysis. Frontiers in Psychiatry 2014;5:80. https://doi.org/10.3389/fpsyt.2014.00080
- George MS, Ward HE Jr, Ninan PT, et al. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimulation 2008;1(2):112-121. https://doi.org/10.1016/j.brs.2008.02.001
- Burger AM, Van der Does W, Thayer JF, Brosschot JF, Verkuil B. Transcutaneous vagus nerve stimulation reduces spontaneous but not induced negative thought intrusions in high worriers. Biological Psychology 2019;142:80-89. https://doi.org/10.1016/j.biopsycho.2019.01.014
- Lin Z, Wang D, Nie Y, Tan C, Liu Z. Transcutaneous auricular vagus nerve stimulation for sleep disorders: a systematic review and meta-analysis of sleep, anxiety, depression, and safety outcomes. Psychology, Health & Medicine 2026:1-26. https://doi.org/10.1080/13548506.2026.2708207
- Goessl VC, Curtiss JE, Hofmann SG. The effect of heart rate variability biofeedback training on stress and anxiety: a meta-analysis. Psychological Medicine 2017;47(15):2578-2586. https://doi.org/10.1017/S0033291717001003
- Fincham GW, Strauss C, Montero-Marin J, Cavanagh K. Effect of breathwork on stress and mental health: a meta-analysis of randomised-controlled trials. Scientific Reports 2023;13:432. https://doi.org/10.1038/s41598-022-27247-y
- Laborde S, Allen MS, Borges U, et al. Effects of voluntary slow breathing on heart rate and heart rate variability: a systematic review and a meta-analysis. Neuroscience & Biobehavioral Reviews 2022;138:104711. https://doi.org/10.1016/j.neubiorev.2022.104711
- Shaffer F, Meehan ZM. A practical guide to resonance frequency assessment for heart rate variability biofeedback. Frontiers in Neuroscience 2020;14:570400. https://doi.org/10.3389/fnins.2020.570400
- Sandercock GR, Bromley PD, Brodie DA. Effects of exercise on heart rate variability: inferences from meta-analysis. Medicine & Science in Sports & Exercise 2005;37(3):433-439. https://doi.org/10.1249/01.mss.0000155388.39002.9d
- Woo M, Kim T. Effects of slow-paced breathing and humming breathing on heart rate variability and affect: a pilot investigation. Physiology & Behavior 2025;299:114972. https://doi.org/10.1016/j.physbeh.2025.114972
- Kinoshita T, Nagata S, Baba R, Kohmoto T, Iwagaki S. Cold-water face immersion per se elicits cardiac parasympathetic activity. Circulation Journal 2006;70(6):773-776. https://doi.org/10.1253/circj.70.773


-2.jpg)